Certain A Shares of Hubei Hongyuan Pharmaceutical Technology Co., Ltd. are subject to a Lock-Up Agreement Ending on 20-MAR-2024. These A Shares will be under lockup for 376 days starting from 10-MAR-2023 to 20-MAR-2024.

Details:
The controlling shareholders and actual controllers Yin Guoping and Yan Xiaohui promise that within 36 months from the date of listing of the company's stocks, will not transfer or entrust others to manage the stocks directly or indirectly hold that have been issued before the company's public offering. shares, nor are the shares repurchased by the company.

Liao Liping, the controlling shareholder and actual controller, undertakes that within 36 months from the date of listing of the company's shares, will not transfer or entrust others to manage the shares that have been issued before the company's public offering that directly or indirectly hold, Neither is the company repurchasing the shares.

Liao Shengru, deputy general manager of the company, promises that within 36 months from the date of listing of the company's shares, will not transfer or entrust others to manage the shares that directly or indirectly hold that have been issued before the company's public offering of shares, nor shall be subject to any additional responsibility. The company repurchased this part of the shares.

Directors and senior executives Xu Shuangxi, Liu Zhanliang, Cheng Siyuan, Deng Zhihua, Zeng Kefeng, Xiao Yonghua and Ding Zhihua who hold the company's shares promise that within 12 months from the date of listing of the company's shares, shall not transfer or entrust others Manage the shares that have been issued before the company's public offering that directly or indirectly hold, and the company will not repurchase such shares.

The supervisors Lei Gaoliang and Duan Xiaoliu who hold the company's shares promise that within 12 months from the date of listing of the company's shares, shall not transfer or entrust others to manage the company's directly or indirectly held shares before the company's public offering. issued shares, nor will the company repurchase such shares.

The company?s shareholder, Hongyuan Foundation, promises that within 36 months from the date of listing of Hongyuan Pharmaceutical?s stock, it will not transfer or entrust others to manage the shares issued before this issuance of Hongyuan Pharmaceutical directly or indirectly held by this unit, and also Hongyuan Pharmaceutical will not repurchase this part of the shares.

The company's shareholders, Hubei Huasheng Construction Co., Ltd., Xingyang (Beijing) Investment Management Co., Ltd., Zhuang Haifang, Tian Jun, Chen Xuan, Guan Hongwei, Wang Xiaojun, Jiang Xiaoxia, Lv Jianguo and Xu Hui, etc. 10 shareholders have made commitments. The newly added shares acquired within one year before the second filing will not be transferred or entrusted to others for management within 36 months from the date of acquisition, nor will Hongyuan Pharmaceuticals repurchase such shares.